Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114562) titled 'Evaluation of the Safety and Performance of Epicare for the Treatment of Periorbital Wrinkles' on Aug. 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Laser team Ltd
Condition:
Wrinkle
Intervention:
Device: Epicare
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 30, 2025
Target Sample Size: 50
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114562
Published by HT Digital Content Services with permission from Health Daily Digest....